Doxycycline Monohydrate NDC 62135-262

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-262Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0262Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62135-262-20	62135026220	20 CAPSULE in 1 BOTTLE (62135-262-20)Marketed from Jun 11, 2021
62135-262-25	62135026225	250 CAPSULE in 1 BOTTLE (62135-262-25)Marketed from Jun 11, 2021
62135-262-50	62135026250	50 CAPSULE in 1 BOTTLE (62135-262-50)Marketed from Jun 11, 2021
62135-262-60	62135026260	60 CAPSULE in 1 BOTTLE (62135-262-60)Marketed from Jun 11, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxycycline Monohydrate
Generic name (nonproprietary): doxycycline monohydrate
Active ingredients: Doxycycline — 100 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Chartwell RX, LLC.
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 050641
Marketing start: Dec 29, 1989
Listing expires: Dec 31, 2026
Other FDA classes: Tetracyclines (Chemical structure)
Identifiers: Product ID 62135-262_3ac1aaae-d186-cf72-e063-6394a90a1dbeSPL ID 3ac1aaae-d186-cf72-e063-6394a90a1dbeSPL set ID 02aa8731-d40f-43d8-8b63-a79a0503f8dbRxCUI 700408, 728207, 1649401, 1649990UNII N12000U13OUPC 0362135262600, 0362135262259, 0362135262501, 0362135260019, 0362135261016, 0362135263607
Pharmacologic class: Tetracycline-class Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135026220 followed by a unit qualifier and the quantity

Package 62135-0262-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 25, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline capsules and other antibacterial drugs, doxycycline capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Doxycycline is indicated for the treatment of the following infections: Rocky mountain spotted fever, typhus fever and the typhus gro…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 050641

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 050641
Product	Strength	Form · route	Labeler	Product NDC
Doxycycline	Doxycycline 150 mg/1	CapsuleOral	Wellhouse Pharma, LLC	85776-300
Doxycycline Monohydrate	Doxycycline 75 mg/1	CapsuleOral	Chartwell RX, LLC.	62135-261
Doxycycline Monohydrate	Doxycycline 50 mg/1	CapsuleOral	Chartwell RX, LLC.	62135-260
Doxycycline Monohydrate	Doxycycline 150 mg/1	CapsuleOral	Chartwell RX, LLC.	62135-263